The healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procurement for safe patient technology delivery. Excessive margins on routine consumables warrant scrutiny, while complex technologies need separate assessment. Maharashtra FDA flagged large gaps between trade prices and MRPs for hospital items. The center has requested a report from the National Pharmaceutical Pricing Authority.
